Targeting DICAM impedes migration of disease-inducing leukocytes into the CNS in multiple sclerosis Jan. 20, 2022
BetterLife reports data from in vivo oral bioavailability and food-effect PK study with BETR-001 Jan. 19, 2022
Once-daily dermal administration of Epoladerm well tolerated in four preclinical studies Jan. 19, 2022
RSS